---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-005521"
form_type: "8-K"
ticker: "ONCO"
cik: "0001782107"
company_name: "Onconetix, Inc."
filed_at: "2025-01-22T23:59:59+00:00"
generated_at: "2026-05-27T20:28:30.320899+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Onconetix settles IQVIA dispute for $150k, records $0.9M reduction in accounts payable

## Summary
- Resolved IQVIA dispute with $150k payment, avoiding claimed $1.09M liability.
- Mutual release of all claims under the Master Services Agreement; no admission of liability.
- Company to reduce accounts payable by approximately $0.9 million as a result of settlement.
- Proteomedix subsidiary posted on LinkedIn about Proclarix study for clinically significant prostate cancer.

## SEC filing metadata
- accession: 0001213900-25-005521
- form_type: 8-K
- ticker: ONCO
- cik: 0001782107
- company_name: Onconetix, Inc.
- filed_at: 2025-01-22T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1782107/000121390025005521/0001213900-25-005521-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1782107/000121390025005521/ea0228132-8k_onconetix.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-005521
- JSON: https://secwatch.observer/filing/0001213900-25-005521.json
- Plain text: https://secwatch.observer/filing/0001213900-25-005521.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.